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patients, elective: 33 (72%), emergent: 13 (28%). One
aneurysm ruptured, 12 caused acute ischemia (12 under-
went thrombolysis+ EVPAR). Mean of 2.0 Viabahn
stent-grafts (range, 1-4) were used. Sixteen procedures
(35%) were performed percutaneously, 30 through femoral
cutdown. Technical success was 98%. Thirty-day mortality
was 4.4%, all after emergencies (15.4%, 2/13). Thirty-day
primary and secondary patencies were 100% for elective,
75% and 84%, respectively for emergencies. Two major
amputations (15.4%) were done after emergent EVPAR.
Early complications were more frequent after emergencies
(77% vs 12%; P < .0001). Intracranial hemorrhage
occurred in one patient (2.2%). Mean follow-up was 2.2
years (30 days-8.6 years). At 2 years, primary patencies
were 70% and 64% (P ¼ .44), secondary patencies 80%
and 84%, (P ¼ .79); no limb was lost in elective cases,
limb salvage was 84% for emergencies (P ¼ .02); reinter-
ventions were similar (19% and 30%); major adverse events
occurred after 20 procedures (44%) (elective, 38%; emer-
gent, 64%; P ¼ .01). There were 5 conversions (elective,
4; emergent, 1). Factors affecting adverse events included
emergent EVPAR and percutaneous placement.
Conclusions: PAA with acute presentation continues
to have elevated mortality (16%) and limb loss (16%).
Although elective EVPAR has excellent early results, 2-
year patency of 80% remains a concern.
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Nothing to disclose; P. Gloviczki: Nothing to disclose;
Y. Huang: Nothing to disclose; M. Kalra: Nothing to
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Clinical Outcome Following Endovascular Therapy for
Femoropopliteal Lesion With TASCII Class A and B
Norihiko Kamioka, Yoshimitsu Soga, Hideaki Aihara,
Yusuke Tomoi, Naotaka Murata, Seiichi Hiramori, Yohei
Kobayashi. Kokura Memorial Hospital, Kitakyushu-city,
Japan
Objectives: The aim of this study was to investigate
the outcome following endovascular therapy(EVT) for
femoropopliteal(FP) lesion classiﬁed into TransAtlantic
Inter-Society Consensus (TASC) II class A and B.
Methods: This study was a multicenter retrospective
analysis. A total of 2742 consecutive patients (3471limbs)
with FP disease and 2003 limbs with TASCII class A and
B lesions were analyzed in current study; 1169 (58.4%)
were stenting, 834 (41.6%) were plain old balloon angio-
plasty (POBA) alone.
Results: The mean follow-up term were 4.6 6 0.1
years. The mean reference vessel diameter (RVD) was 58.7
6 33.8 mm and the mean lesion length was 5.2 6 1.0
mm. Primary patency was signiﬁcantly higher in the stent
group (85.3%, 69.6% and 59.9% at 1, 3 and 5 years) than
that in the POBA group (76.2%, 59.6% and 49.3% at 1, 3
and 5 years; P < .0001). Assisted primary patency was also
better in the stent group than that in the POBA group
(P ¼ .0002) and the difference in secondary patencybetween in the two groups was similarly signiﬁcant (P ¼
.006). Limited to lesions with RVD below 4.5 mm, there
was no difference in primary patency between in the two
groups (stent vs POBA; 73.0% vs 74.8%, 57.2% vs 53.2%
and 46.8% vs 45.4% at 1, 3 and 5 years; P ¼ .67). Diabetes,
hemodialysis, the history of cerebrovascular disease, absence
of cilostazol, POBA alone andRVD<4.5mmwere found to
be independent predictors of primary patency.
Conclusions: FP stenting improves the primary, assis-
ted-primary and secondary patency for the femoropopliteal
TASCII class A and B lesions.Author Disclosures: H. Aihara: Nothing to disclose;
S. Hiramori: Nothing to disclose; N. Kamioka: Nothing
to disclose; Y. Kobayashi: Nothing to disclose; N. Mur-
ata: Nothing to disclose; Y. Soga: Nothing to disclose;
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Predictors of 30-Day Readmission and Postdischarge
Mortality Following Lower Extremity Amputation in
the ACS-NSQIP
ThomasCurran,Margriet Fokkema,RubyC.Lo,MarkWyers,
Allen Hamdan, Elliot Chaikof, Marc L. Schermerhorn.
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Objectives: Postoperative readmission is associated
with increased morbidity and mortality. We evaluated risk
factors for readmission and postdischarge adverse events
following lower extremity amputation in the ACS-NSQIP.
Methods: All patients undergoing transmetatarsal
(TMA), below-knee (BKA) or above-knee amputation
(AKA) in the 2011 NSQIP were identiﬁed. Independent
predictors of 30-day readmission were determined using
multivariable logistic regression.
Results: 3438 patients underwent amputation (TMA,
12%; BKA, 50%; AKA, 38%). Readmission rate was 18%.
Thirty-day mortality rate was 8.3% (TMA, 3%; BKA, 6%;
AKA, 13%; P < .01) with 44% of deaths occurring post-
discharge. Overall complication rate was 47% (in-hospital,
41%; postdischarge, 9%). Postdischarge complications
were readmitted in 71% of cases. Amputation level was
not associated with increased complication rate or readmis-
sion rate. Independent predictors of readmission included
OR take-back (OR, 7.0; 95% CI, 5.4-9.0), preoperative
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1.5-4.1), dependent functional status (OR, 1.6; 95% CI,
1.2-2.2), history of lower extremity bypass (OR, 1.5; 95%
CI, 1.1-1.9), preoperative dialysis (OR, 1.4; 95% CI, 1.1-
1.7), pulmonary comorbidity (OR, 1.4; 95% CI, 1.0-1.5)
and ASA S 4 (OR, 1.3; 95% CI, 1.0-1.5).
Conclusions: Postdischarge morbidity, mortality and
readmission are common following lower extremity ampu-
tation. Closer follow up of high risk patients, optimization
of medical comorbidities and aggressive management of
wound infection may decrease readmission and postdi-
scharge adverse events.Table.
Complication
30-day
rate, %
Postdischarge
rate, %
Readmission
rate for
postdischarge
event, %
Any complication 47 9 71
Any wound
complication
9 5 69
Sepsis 7 2 86
Respiratory failure 6 1 93
UTI 4 2 62
Pneumonia 4 1 90
MI 2 <1 100
Table.
LS, %
Toes only Foot Leg
(-) Infection (+) (-) Infection (+) (-) Infection (+)
Ulcer 88 79 89 57a 100 100
Gangrene 82 42a 57a 54a 0a 0a
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Impact of Tissue Loss on Limb Salvage After
Revascularization
Monica O’Brien-Irr2, Linda M. Harris1, Hasan H.
Dosluoglu3, Gregory Cherr1, Sonya Noor1, George R.
Curl1, Maciej Dryjski1. 1Dept of Surgery, Buffalo General
Medical Center, Buffalo, NY; 2University at Buffalo,
Buffalo,NY; 3VAWesternNewYorkHealthcare,Buffalo,NY
Objectives: To evaluate the impact of tissue loss (TL)
classiﬁcation, location and presence of infection on limb
salvage (LS) following revascularization for lower extremity
peripheral arterial disease (PAD).
Methods: A retrospective medical record review was
completed of all patients revascularized for TL during
2009.
Results: There were 110 revascularizations. Major
early amputation (mean time, 4 months) was required in
30% due to inadequate healing and was more likely in those
with gangrene than ulcer (46% vs 15%; P ¼ .005) or infec-
tion (42% vs 21%; P ¼ .05) but did not differ by location
(P ¼ .57). Amputation risk was identiﬁed by composite
evaluation; Low risk: ulcers and non-infected toe gangrene,
High risk: infected foot ulcers and all other gangrene
(Table). LS was higher in low risk (86% vs 46%; P <.001) as was favorable outcome (improved/healed TL):
62% vs 33%: P ¼ .04. Comorbidities, postoperative compli-
cations, pre/post runoff, did not differ between low and
high risk. LS was related to prerunoff for high risk;
increasing from 0-3 vessels (0%, 47%, 64%, 75%; P ¼
.028); but not for low risk; 80% with 0 runoff to 87%, 1-
3 vessel runoff; P ¼ .28.
Conclusions: Composite evaluation of TL is valuable
in identifying patients likely to beneﬁt from revasculariza-
tion. Infected toe gangrene/foot ulcers or any foot/leg
gangrene carry high risk for Amputation. Runoff plays
a key role for LS in this group but may be less critical to
those with lower risk TL.Author Disclosures: G. Cherr: Nothing to disclose;
G. R. Curl: Nothing to disclose; H. H. Dosluoglu:
Nothing to disclose; M. Dryjski: Nothing to disclose;
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Lower Extremity Peripheral Artery Disease Screening
in Adults With Diabetes Mellitus
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Jordan. Vascular Surgery, University of Alabama at
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Objectives: The prevalence of peripheral artery disease
(PAD) in the general population is estimated to be 3%-10%.
Patients with diabetes mellitus (DM) are known to have
greater risk of developing PAD but its contribution is
unclear. Prospective screening was initiated for DM patients
to determine prevalence, risk factors and outcome for PAD.
Methods: We enrolled 511 DM patients into
a screening study. Lower extremity (LE) vascular screening
was completed on 473 participants including history
(subjective symptoms) focusing on pain, LE vascular inter-
ventions, walking distance, tissue loss and physical exami-
nation (objective symptoms) with LE pulse exam, ankle
brachial index, and duplex ultrasound of the superﬁcial
femoral artery. A positive screening was deﬁned as symp-
toms of PAD or abnormal objective ﬁndings. SPSS
(IBM) was used for statistical analysis.
Results: Of the 473 patients, 188 (39.7%) screened
positive; subjective symptoms were positive in 108
(57.4%), objective in 134 (71.2%) and 54 patients
(28.7%) were positive on both. The main subjective symp-
toms were pain (89%) and walking distance (40.1%) and
the main objective symptoms were presence of plaque
(69%) and absence of pulses (44.7%). Signiﬁcant difference
was reached for mean age (546 13.3 neg vs 57.96 13 pos
[yrs]; P < .01) and for time from DM diagnosis to
